| Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells X Zhu, M Badawi, S Pomeroy, DS Sutaria, Z Xie, A Baek, J Jiang, ... Journal of extracellular vesicles 6 (1), 1324730, 2017 | 472 | 2017 |
| Achieving the promise of therapeutic extracellular vesicles: the devil is in details of therapeutic loading DS Sutaria, M Badawi, MA Phelps, TD Schmittgen Pharmaceutical research 34, 1053-1066, 2017 | 130 | 2017 |
| Low active loading of cargo into engineered extracellular vesicles results in inefficient miRNA mimic delivery DS Sutaria, J Jiang, OA Elgamal, SM Pomeroy, M Badawi, X Zhu, ... Journal of extracellular vesicles 6 (1), 1333882, 2017 | 84 | 2017 |
| Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen D Sutaria, BK Grandhi, A Thakkar, J Wang, S Prabhu International journal of oncology 41 (6), 2260-2268, 2012 | 81 | 2012 |
| First penicillin-binding protein occupancy patterns of β-lactams and β-lactamase inhibitors in Klebsiella pneumoniae DS Sutaria, B Moya, KB Green, TH Kim, X Tao, Y Jiao, A Louie, ... Antimicrobial agents and chemotherapy 62 (6), 10.1128/aac. 00282-18, 2018 | 80 | 2018 |
| The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer A Thakkar, D Sutaria, BK Grandhi, J Wang, S Prabhu Oncology Reports 29 (4), 1671-1677, 2013 | 58 | 2013 |
| Globally increased ultraconserved noncoding RNA expression in pancreatic adenocarcinoma J Jiang, ACP Azevedo-Pouly, RS Redis, EJ Lee, Y Gusev, D Allard, ... Oncotarget 7 (33), 53165, 2016 | 42 | 2016 |
| CD44 positive and sorafenib insensitive hepatocellular carcinomas respond to the ATP-competitive mTOR inhibitor INK128 M Badawi, J Kim, A Dauki, D Sutaria, T Motiwala, R Reyes, N Wani, ... Oncotarget 9 (40), 26032, 2018 | 38 | 2018 |
| miR-216 and miR-217 expression is reduced in transgenic mouse models of pancreatic adenocarcinoma, knockout of miR-216/miR-217 host gene is embryonic lethal ACP Azevedo-Pouly, DS Sutaria, J Jiang, OA Elgamal, F Amari, D Allard, ... Functional & integrative genomics 17, 203-212, 2017 | 35 | 2017 |
| Comparable efficacy and better safety of double β-lactam combination therapy versus β‑lactam plus aminoglycoside in gram-negative bacteria in randomized, controlled trials Y Jiao, B Moya, MJ Chen, AP Zavascki, H Tsai, X Tao, DS Sutaria, ... Antimicrobial Agents and Chemotherapy 63 (7), 10.1128/aac. 00425-19, 2019 | 31 | 2019 |
| Chemoprevention of colon cancer in a rat carcinogenesis model using a novel nanotechnology-based combined treatment system A Chaudhary, D Sutaria, Y Huang, J Wang, S Prabhu Cancer prevention research 4 (10), 1655-1664, 2011 | 30 | 2011 |
| First penicillin-binding protein occupancy patterns for 15 β-lactams and β-lactamase inhibitors in Mycobacterium abscessus ARM Sayed, NR Shah, KB Basso, M Kamat, Y Jiao, B Moya, DS Sutaria, ... Antimicrobial agents and chemotherapy 65 (1), 10.1128/aac. 01956-20, 2020 | 19 | 2020 |
| Expression profiling identifies the noncoding processed transcript of HNRNPU with proliferative properties in pancreatic ductal adenocarcinoma DS Sutaria, J Jiang, ACP Azevedo-Pouly, EJ Lee, MR Lerner, DJ Brackett, ... Non-coding RNA 3 (3), 24, 2017 | 19 | 2017 |
| Novel cassette assay to quantify the outer membrane permeability of five β-lactams simultaneously in carbapenem-resistant Klebsiella pneumoniae and Enterobacter cloacae TH Kim, X Tao, B Moya, Y Jiao, KB Basso, J Zhou, Y Lang, DS Sutaria, ... MBio 11 (1), 10.1128/mbio. 03189-19, 2020 | 18 | 2020 |
| Knockout of acinar enriched microRNAs in mice promote duct formation but not pancreatic cancer DS Sutaria, J Jiang, AC Azevedo-Pouly, L Wright, JA Bray, K Fredenburg, ... Scientific reports 9 (1), 11147, 2019 | 14 | 2019 |
| Loss of RE-1 silencing transcription factor accelerates exocrine damage from pancreatic injury JK Bray, OA Elgamal, J Jiang, LS Wright, DS Sutaria, M Badawi, ... Cell Death & Disease 11 (2), 138, 2020 | 13 | 2020 |
| Combating multidrug‐resistant bacteria by integrating a novel target site penetration and receptor binding assay platform into translational modeling Y Lang, NR Shah, X Tao, SM Reeve, J Zhou, B Moya, ARM Sayed, ... Clinical Pharmacology & Therapeutics 109 (4), 1000-1020, 2021 | 12 | 2021 |
| Novel population pharmacokinetic approach to explain the differences between cystic fibrosis patients and healthy volunteers via protein binding NR Shah, JB Bulitta, M Kinzig, CB Landersdorfer, Y Jiao, DS Sutaria, ... Pharmaceutics 11 (6), 286, 2019 | 10 | 2019 |
| Novel cassette assay to quantify the outer membrane permeability of five β-lactams simultaneously in carbapenem-resistant Klebsiella pneumoniae and Enterobacter cloacae. mBio … TH Kim, X Tao, B Moya, Y Jiao, KB Basso, J Zhou, Y Lang, DS Sutaria, ... | 8 | 2020 |
| First population pharmacokinetic analysis showing increased quinolone metabolite formation and clearance in patients with cystic fibrosis compared to healthy volunteers Y Jiao, TH Kim, X Tao, M Kinzig, CB Landersdorfer, SK Drescher, ... European Journal of Pharmaceutical Sciences 123, 416-428, 2018 | 8 | 2018 |
Thomas D. SchmittgenProfessor of Pharmaceutics University of Florida在 ufl.edu 的电子邮件经过验证
